[HTML][HTML] Microglia: the real foe in HIV-1-associated neurocognitive disorders?
A Borrajo López, MA Penedo, T Rivera-Baltanas… - Biomedicines, 2021 - mdpi.com
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
A Borrajo López, MA Penedo… - …, 2021 - search.ebscohost.com
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
[HTML][HTML] Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
AB López, MA Penedo, T Rivera-Baltanas… - …, 2021 - ncbi.nlm.nih.gov
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
MA Penedo, T Rivera-Baltanas, D Pérez-Rodríguez… - Biomedicines, 2021 - europepmc.org
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
[PDF][PDF] Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?. Biomedicines 2021, 9, 925
A Borrajo López, MA Penedo, T Rivera-Baltanas… - 2021 - pdfs.semanticscholar.org
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
AB López, MA Penedo, T Rivera-Baltanas… - …, 2021 - search.proquest.com
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
AB López, MA Penedo, T Rivera-Baltanas… - 2021 - agris.fao.org
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
[引用][C] Microglia: The real foe in hiv-1-associated neurocognitive disorders?
AB López, MA Penedo, T Rivera-Baltanas… - …, 2021 - produccioncientifica.ucm.es
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
AB López, MA Penedo, T Rivera-Baltanas… - …, 2021 - pubmed.ncbi.nlm.nih.gov
The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …